Financial Instruments

3 Months Ended

Mar. 31, 2025

Investments, All Other Investments [Abstract]

Financial Instruments

4. Financial Instruments

The following table summarizes the Company’s cash and cash equivalents, amortized cost, gross unrealized gains, gross unrealized losses, and fair value by significant category reported as cash and cash equivalents and restricted cash as of March 31, 2025 and December 31, 2024:

	March 31, 2025
	Reported as:
(in thousands)	Cash and Cash Equivalents		Restricted Cash- current
Cash	$	1,463	$	-
Level 2
Money market funds		9,138		88
Subtotal		9,138		88
Total assets measured at fair value	$	10,601	$	88

	December 31, 2024
	Reported as:
(in thousands)	Cash and Cash Equivalents		Restricted Cash- current
Cash	$	969	$	-
Level 2
Money market funds		11,248		219
Subtotal		11,248		219
Total assets measured at fair value	$	12,217	$	219

Interest income recorded for these cash and investments was $0.1 million and $0.7 million during the three months ended March 31, 2025, and the year ended December 31, 2024, respectively.

As of March 31, 2025, and December 31, 2024, the Company did not have any financial assets classified as Level 1 or Level 3. The contingent consideration is carried at fair value and is a Level 3 financial liability. See further discussion of the contingent consideration in Note 3.